Strengthening Pharma–CDMO Collaboration to Navigate Environmental Regulations & Achieve Shared Sustainability Goals
3:45 pm - Wednesday 17th March 2027
- Address environmental compliance challenges when pharma sponsors dictate materials and manufacturing processes, while CDMOs must manage the resulting site-level risks and regulatory obligations
- Strengthen sponsor–CDMO communication to anticipate regulatory changes, assess manufacturing capabilities and secure the capital investment needed to maintain compliance
- Align EHS, sustainability and operations teams across the supply chain to eliminate conflicting priorities, coordinate environmental improvements and meet shared compliance and ESG targets